Romosozumab plus alendronate led to a greater improvement in bone strength than alendronate alone in postmenopausal women ...

Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two U.S. Phase II clinical trials ...

Iantrek has reached an exciting milestone as we transition from development of our bio-interventional technologies to ...

We present a case of unilateral, secondary open-angle glaucoma due to an underlying diffuse iris melanoma. The patient was referred by his ophthalmologist with uncontrolled, elevated intraocular ...

Researchers recently published a study in Materials on the tailoring of porous Ti6AL4V for biomedical purposes.

Treatment with romosozumab led to improvements in bone microarchitecture among postmenopausal women with osteoporosis.